Evidence map›Paper›PMID 39582415›Full record

ArticleBirth defects research2024

Prevalence of Congenital Ocular Anomalies in 15 Countries of Europe: Results From the Medikeye Study.

Charlotte Dubucs, Anthony Caillet, Félix Frémont, Laurane Delteil, Van N'Go, Amanda Julie Neville, Elisa Ballardini, Helen Dolk, Maria Loane, Ester Garne and 24 more

Abstract read
In one paragraph

Article in Birth defects research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Charlotte DubucsUnité de Pharmacoépidémiologie, UMR CERPOP, INSERM, Université de Toulouse, Toulouse, France.ORCID 0000-0003-2371-4113
Anthony CailletUnité de Pharmacoépidémiologie, UMR CERPOP, INSERM, Université de Toulouse, Toulouse, France.
Félix FrémontService d'ophtalmologie, Hôpital Pierre-Paul Riquet, CHU Toulouse-Purpan, Toulouse, France.
Laurane DelteilUnité de Pharmacoépidémiologie, UMR CERPOP, INSERM, Université de Toulouse, Toulouse, France.
Van N'GoUnité de Pharmacoépidémiologie, UMR CERPOP, INSERM, Université de Toulouse, Toulouse, France.
Amanda Julie NevilleCentre for Clinical and Epidemiological Research, University of Ferrara and Azienda, Ospedaliero Universitario di Ferrara, Ferrara, Italy.
Elisa BallardiniNeonatal Intensive Care Unit, University Hospital of Ferrara, IMER Registry (Emilia Romagna Registry of Birth Defects), Ferrara, Italy.
Helen DolkSchool of Medicine, Ulster University, Belfast, Northern Ireland, UK.ORCID 0000-0001-6639-5904
Maria LoaneInstitute of Nursing and Health Research, Ulster University, Belfast, Northern Ireland, UK.ORCID 0000-0002-1206-3637
Ester GarneDepartment of Paediatrics and Adolescent Medicine, Lillebaelt Hospital, University Hospital of Southern Denmark, Kolding, Denmark.ORCID 0000-0003-0430-2594
Babak KhoshnoodINSERM U953, Hopital Saint Vincent de Paul, Paris, France.
Nathalie LelongINSERM U953, Hopital Saint Vincent de Paul, Paris, France.
Anke RissmannMalformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.ORCID 0000-0002-9437-2790
Mary O'MahonyDepartment of Public Health, St. Finbarr's Hospital, Cork, Ireland.
Anna PieriniUnit of Epidemiology of Rare Diseases and CA, Institute of Clinical Physiology-National Research Council, Pisa, Italy.
Miriam GattMalta CA Register, Directorate for Health Information and Research, Pietà, Malta.
Jorieke BergmanDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0002-3929-3619
Maciej Robert KrawczynskiDepartment of Medical Genetics, Poznan University of Medical Science, Poznan, Poland.
Anna Latos BielenskaDepartment of Medical Genetics, Poznan University of Medical Science, Poznan, Poland.
Luis Javier Echevarría González de GaribayDepartment of Health of the Basque Government, Vitoria-Gasteiz, Spain.
Clara Cavero-CarbonellRare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.
Marie-Claude AddorDepartment of Woman-Mother-Child, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
David TuckerPublic Health Wales, Public Health Knowledge and Research, Singleton Hospital, Swansea, Wales, UK.
Sue JordanFaculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK.
Elly Den HondProvincial Institute of Hygiene, Antwerp, Belgium.
Vera NelenProvincial Institute of Hygiene, Antwerp, Belgium.
Ingeborg BarisicCentre of Excellence for Reproductive and Regenerative Medicine, Medical School University of Zagreb, Zagreb, Croatia.
Florence RougetDepartment of Neonatology, University Hospital, Rennes, France.
Hanitra RandrianaivoUnit of Congenital Malformations, REMACOR-Medical School University of La Réunion St. Pierre, Sainte-Clotilde/Register of Reunion Island CHU LA REUNION, Réunion, France.
Jonathan HoareauUnit of Congenital Malformations, REMACOR-Medical School University of La Réunion St. Pierre, Sainte-Clotilde/Register of Reunion Island CHU LA REUNION, Réunion, France.
Isabelle PerthusGénétique médicale, CHU Estaing, Centre d'Etude Des Malformations Congénitales en Auvergne, Clermont-Ferrand, France.
Caroline Hurault-DelarueUnité de Pharmacoépidémiologie, UMR CERPOP, INSERM, Université de Toulouse, Toulouse, France.
Monique Courtade-SaïdiDépartement d'Anatomie et Cytologie Pathologiques, IUCT-Oncopole, Toulouse, France.
Christine Damase-MichelUnité de Pharmacoépidémiologie, UMR CERPOP, INSERM, Université de Toulouse, Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCongenital ocular anomalies (COA) are among the most common causes of visual impairment in children in high-income countries. The aim of the study is to describe the prevalence of the various COA recorded in European population-based registries of CA (EUROCAT) participating in the EUROmediCAT consortium.

methodsData from 19 EUROmediCAT registries and one healthcare database (EFEMERIS) were included in this descriptive epidemiological study. Cases of COA included live births, FD from 20 weeks gestational age (GA), and termination of pregnancy for fetal anomaly.

resultsThe prevalence of total COA was 3.47/10,000 births (95% CI [3.61-3.82]), ranging from 1.41 to 13.46/10,000 depending on the registry. Among COA cases, congenital lens anomalies were the most frequent anomalies (31%), of which over half were single ocular anomalies (presenting with only one ocular anomaly). An/microphthalmia was the second most frequent COA (24%) of which three-quarters were multiply malformed (associated to extraocular major anomalies). Among single COA cases, 58 were prenatally diagnosed (4%), of which, 58% were diagnosed in the second trimester. Known genetic causes of COA explained 2.5%-25% of COA depending on their class.

conclusionsThis is the first European study describing COA. The detailed prevalence data offered in this study could improve screening and early diagnosis of different classes of COA. As COA are rare, epidemiological surveillance of large populations and accurate clinical descriptions are essential.

Indexed as

Eye AbnormalitiesRegistriesEuropeFemaleGestational AgeHumansInfant, NewbornMalePregnancyPrenatal DiagnosisPrevalencecongenital ocular anomaliesdescriptive epidemiological studyepidemiologyEuropeocular defect

Identifiers

PMID39582415
PMCPMC11586828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.